Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
NGeneR logo — Make every day progress for better health.

NGeneR

Make every day progress for better health.

Founded 2020 Denmark Denmark 2-10 employees Biotechnology, Health Care

General Information

Company Name NGeneR
Founded Year 2020
Location Denmark Denmark
Employees 2-10
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with NGeneR. To contact NGeneR, visit ngener.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NGeneR compare?

A PDF of NGeneR and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NGeneR soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NGeneR

NGeneR is a biotechnology and healthcare startup based in Denmark, founded in 2020. The company's slogan, "Make every day progress for better health," reflects its mission to provide services and products for DNA sequencing and analyses. Using artificial intelligence, NGeneR offers a range of affordable products that bring awareness to customers regarding genetic diseases. Despite its recent establishment, NGeneR has not disclosed its last investment or the involved investors. Overall, NGeneR aims to revolutionize healthcare by making genetic testing and disease awareness more accessible to the general population. With its focus on leveraging artificial intelligence for DNA analysis, NGeneR is positioned at the forefront of biotechnology innovation. This aligns with the growing trend of personalized medicine and preventive healthcare, presenting a promising opportunity for potential investors seeking to support pioneering solutions in the healthcare sector.

Business keywords: DNA sequencing, genetic analysis, health awareness, genetic diseases, genomics, personalized medicine

No funding data available for NGeneR yet.

NGeneR Alternatives & Competitors

View All Alternatives
NGeneR vs
IntegraGen
IntegraGen France

Company specializing in the genomics of cancer and genetic diseases

Post-IPO Equity
50 employees
Biotechnology, Health Care
NGeneR vs
Secugen S.L.
Secugen S.L. Spain

Secugen is a company specialized in Automatic DNA Sequencing and Genetic Diagnostic services.

13 employees
Biotechnology, Health Care
NGeneR vs
Genoplan
Genoplan Korea South

유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플랜코리아 입니다.

Series C
16 employees
AI, Analytics
Also compare with: NGeneR vs GenoScreen GenoScreen View all alternatives

FAQ About NGeneR

Make every day progress for better health.
NGeneR was founded in 2020.
NGeneR is headquartered in Denmark.
NGeneR operates in Biotechnology and Health Care. Its work centres on DNA sequencing, genetic analysis, health awareness and genetic diseases.
NGeneR has approximately 2-10 employees.
Top alternatives and competitors to NGeneR include IntegraGen, Secugen S.L., Genoplan , Personalbio, Mendelics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NGeneR and IntegraGen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NGeneR, https://bouncewatch.com/company/ngener, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout